Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge

BACKGROUND: There is no well‐established late‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Therefore, we retrospectively determined the efficacy and safety of platinum rechallenge with paclitaxel‐carboplatin and bevacizumab in patients with nonsquamous NSCLC as a late‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugisaka, Jun, Toi, Yukihiro, Kawashima, Yosuke, Domeki, Yutaka, Aiba, Tomoiki, Kawana, Sachiko, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Sugawara, Shunichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626222/
https://www.ncbi.nlm.nih.gov/pubmed/37699787
http://dx.doi.org/10.1111/1759-7714.15107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626222/
https://www.ncbi.nlm.nih.gov/pubmed/37699787
http://dx.doi.org/10.1111/1759-7714.15107

Ejemplares similares